English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Press Releases for Thursday, November 14, 2024
Lexaria Signs Contract for New DehydraTECH GLP-1 Biodistribution Study 
22:10 HKT/SGT
Explore the Next Era of DevOps at Exito's DevOps Summit in Dubai 
21:04 HKT/SGT
MINGAONE Unveils Direct-to-Accommodation Red Ginseng Delivery Service for Foreign Tourists in Korea 
21:00 HKT/SGT
MINGAONE Unveils Direct-to-Accommodation Red Ginseng Delivery Service for Foreign Tourists in Korea 
20:00 HKT/SGT
myBillBook Leverages CleverTap to Elevate Customer Engagement and Drive Revenue Growth 
19:00 HKT/SGT
TANAKA gelingt die Entwicklung der weltweit ersten[1] Fertigungstechnologie für Platinwerkstoffe mit Kristallkörnern in Nanogröße 
17:00 HKT/SGT
Disney Dream Reimagined! New Little Mermaid Wedding Ring Collection 
14:00 HKT/SGT
NEC、量子科学技術研究開発機構および核融合科学研究所から次期スーパーコンピュータシステムを受注 
12:00 HKT/SGT
ニュートン バイオキャピタル、日本の創薬スタートアップのテンセグリティファーマに対し、第 2 号ファンドより、日本初の投資を発表 
11:00 HKT/SGT
COP29: PLN Encourages Global Collaboration for Energy Transition Towards Sustainable Energy Self-Sufficiency 
11:00 HKT/SGT
田中貴金屬:全球首創※1成功開發出具有奈米級晶粒的白金材料製造技術 
11:00 HKT/SGT
ニュートン バイオキャピタル、⽇本の創薬スタートアップのテンセグリティファーマに対し、第 2 号ファンドより、⽇本初の投資を発表 
11:00 HKT/SGT
田中贵金属:行业首款※1、具有纳米尺寸晶粒的白金材料制造技术开发成功 
11:00 HKT/SGT
Academic Labs, the Pioneering Crypto Platform Achieves a $300M at Its ICO 
10:00 HKT/SGT
Blueberry Rebrand Reflects Exciting New Era for the Forex Company 
10:00 HKT/SGT
다나까귀금속공업, 세계 최초※1, 나노 크기의 결정입자를 가진 백금 소재 제조 기술 개발 성공 
10:00 HKT/SGT
Academic Labs, the Pioneering Crypto Platform Achieves a $300M at Its ICO 
09:00 HKT/SGT
Blueberry Rebrand Reflects Exciting New Era for the Forex Company 
09:00 HKT/SGT
ULVAC Launches Oil Rotary Vacuum Pump Gv135 
09:00 HKT/SGT
Femto Technologies Announces Third Quarter 2024 Financial Results 
07:00 HKT/SGT
 ACN Search:
 
Viberse launches Tango: A playful way to meet new faces worldwide
 
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575